Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA meetings

This article was originally published in The Tan Sheet

Executive Summary

FDA's first public meeting has been postponed and will be rescheduled at a later date due to "the need to focus on Hurricane Katrina relief efforts," the agency announced Sept. 8. The meeting, originally scheduled for Sept. 13 in Miami, Fla., is the first in a three-part series entitled, "Vision 2006 - A Conversation with the American Public." Designed as an open forum where FDA can update the public on agency programs and engage in public discussion, the meetings are expected to be attended by Commissioner Lester Crawford and other top leadership ("1The Tan Sheet" Aug. 22, 2005, p. 9)....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098628

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel